Trials / Completed
CompletedNCT00032708
Dryvax Dilution-Prev Vacc Adults
A Double Blind, Randomized Dose Response Study of Dryvax Vaccine Against Smallpox in Previously Vaccinated Adults
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (planned)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID) · NIH
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
A double-blind, randomized, dose-response study of four dilutions of Dryvax in previously vaccinated adults in order to assess the clinical success rates, humoral responses, and virus-specific actifity of cytotoxi T cells and interferon-y producing T cells
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Dryvax |
Timeline
- Start date
- 2004-04-01
- Completion
- 2004-11-01
- First posted
- 2002-03-29
- Last updated
- 2010-08-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00032708. Inclusion in this directory is not an endorsement.